Pharmaceutical Markets in Brazil, Russia, India and China ( BRIC nations )

Table of Contents

• Overview
• Scope and Methodology
• Size and Growth of the Market
• Key Issues and Trends Affecting the Market
• Leading Competitors

• Overview
• Intellectual Property Rights and Compulsory Licensing
• Biosimilar Production
• Ethical Issues Regarding DTC Advertising in Developing Regions
• World Health
  • Tobacco Use
  • Obesity
• World Economic Trends
• Purchasing Power Trends

• Overview and Summary
• Regulatory Environment
• Economic Development
• Healthcare Trends in India
  • Healthcare Professionals
• Demographics
  • Birth Rates
  • Life Expectancy
  • Mortality
  • Leading Causes of Death
• Key Product Segments and Market Indicators
  • Cardiovascular Drugs
  • Gastrointestinal Drugs
  • Infection Control Drugs
  • Neurotherapuetics and Central Nervous System Drugs
  • Oncology Drugs
  • Respiratory Drugs
  • Other Drugs
• Market Analysis
  • Product Segment Market Analysis
  • Competitive Outlook and Distribution

• Overview and Summary
  • Regulatory Environment
  • Economic Development
  • Healthcare Trends in China
  • Healthcare Professionals
• Demographics
  • Birth Rates
  • Life Expectancy
  • Mortality
  • Leading Causes of Death
• Key Product Segments and Market Indicators
  • Cardiovascular Drugs
  • Gastrointestinal Drugs
  • Infection Control Drugs
  • Neurotherapuetics and Central Nervous System Drugs
  • Oncology Drugs
  • Respiratory Drugs
  • Other Drugs
• Market Analysis
  • Product Segment Market Analysis
  • Competitor Outlook and Distribution

• Overview and Summary
• Regulatory Environment
• Economic Development
• Healthcare Trends in Russia
• Healthcare Professionals
• Demographics
  • Birth Rates
  • Life Expectancy
  • Mortality
  • Leading Causes of Death
• Key Product Segments and Market Indicators
  • Cardiovascular Drugs
  • Gastrointestinal Drugs
  • Infection Control Drugs
  • Neurotherapuetics and Central Nervous System Drugs
  • Oncology Drugs
  • Respiratory Drugs
  • Other Drugs
• Market Analysis
• Product Segment Market Analysis
• Competitive Outlook and Distribution

• Overview and Summary
• Regulatory Environment
• Economic Development
• Healthcare Trends in Brazil
• Healthcare Professionals
• Demographics
  • Birth Rates
  • Life Expectancy
  • Mortality
  • Leading Causes of Death
• Key Product Segments and Market Indicators
  • Cardiovascular Drugs
  • Gastrointestinal Drugs
  • Infection Control Drugs
  • Neurotherapuetics and Central Nervous System Drugs
  • Oncology Drugs
  • Respiratory Drugs
  • Other Drugs
• Market Analysis
• Product Segment Market Analysis
• Competitive Outlook and Distribution

• Overview
• Markets by Country

• Overview
• AstraZeneca
• GlaxoSmithKline
• Novartis AG
• Pfizer, Inc.
• Roche
• Sanofi-Aventis

APPENDIX: LIST OF MAJOR COMPANIES LIST OF EXHIBITS

• Figure 1-1: BRIC Market Analysis: 2005-2012

• Table 2-1: Percent of Smokers by Country, Adult Population 15+
• Table 2-2: Percent of Population that is Obese*, Estimated 2005
• Table 2-3: Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006
• Figure 2-1: Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006
• Table 2-4: Gross National Income Comparison by Country 2000-2005
• Figure 2-2: Gross National Income Growth by Country 2000-2005

• Table 3-1: India Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
• Figure 3-1: India Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
• Table 3-2: India' s Economic Profile
• Table 3-3: Gross National Income Per Capita and Growth Comparison for 2005 and 2006
• Table 3-4: Healthcare Professionals in India by Type, Estimated 2004 and 2007
• Figure 3-2; Healthcare Professionals in India by Type, Estimated 2004 and 2007
• Table 3-5: India - Midyear Population, by Age and Sex, 2007 and 2012
• Figure 3-3: India - Midyear Population, by Age, 2007 and 2012
• Table 3-6: India Fertility Rates and Births Estimated 2005, 2007; Projected 2008, 2025
• Figure 3-4: India Fertility Rates and Births, Estimated 2005, 2007; Projected 2008, 2025
• Table 3-7: India Life Expectancy at Birth, 1980, 1990, 2000, 2004, 2005, 2006, 2007; Projections, 2008 through 2012, and 2025
• Figure 3-5: India Life Expectancy at Birth by Sex, 1980, 1990, 2000, Projections 2025
• Table 3-8: India Mortality Rates and Numbers (Estimated 2005, 2007; Projected 2008, 2025)
• Figure 3-6: India Mortality Rates and Numbers (Estimated 2005, 2007; Projected 2008, 2025)
• Table 3-9: India Leading Causes of Death, Estimated 2007
• Figure 3-7: India Leading Causes of Death, Estimated 2007
• Table 3-10: HIV Indicators, India
• Figure 3-8: HIV Indicators, India
• Table 3-11: Tuberculosis Surveillance and Epidemiology, India
• Figure 3-9: Tuberculosis Surveillance and Epidemiology, India
• Table 3-12: India Malaria Data, 1990-2003
• Figure 3-10: India Malaria Data, 1990-2003
• Table 3-13: Cancer Surveillance and Epidemiology, India
• Table 3-14: Estimated Cancer Incidence in India by Most Common Types of Cancer, Compared to World
• Figure 3-12: Estimated Cancer Incidence in India by Most Common Types of Cancer, Compared to World, 2007
• Table 3-15: India Pharmaceutical Market Analysis, 2005-2007
• Table 3-16: Forecasted India Pharmaceutical Market Analysis: 2008-2012
• Figure 3-13: India Pharmaceutical Market Analysis: 2005-2012
• Table 3-17: India Pharmaceutical Market Analysis and Forecast by Product Segment, 2007 and 2012
• Figure 3-14: India Pharmaceutical Market Analysis by Product Segment, 2007
• Figure 3-15: India Pharmaceutical Market Forecast by Product Segment, 2012
• Table 3-18: Estimated Sales of Pharmaceuticals in India by Local and Foreign Suppliers, 2007
• Figure 3-16: Estimated Sales of Pharmaceuticals in India by Local and Foreign Suppliers, 2007

• Table 4-1: China Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
• Figure 4-1: China Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
• Table 4-2: Chinese and U.S. Drug Review Timeline
• Table 4-3: China' s Economic Profile
• Table 4-4: Gross National Income Per Capita and Growth Comparison for 2005 and 2006
• Table 4-5: Healthcare Professionals in China by Type, Estimated 2004 and 2007
• Figure 4-2: Healthcare Professionals in China by Type, Estimated 2004
• Table 4-6: China - Midyear Population, by Age and Sex, 2007 and 2012
• Figure 4-3: China - Midyear Population, by Age, 2007 and 2012
• Table 4-7: China Fertility Rates and Births (Estimated 2005, 2007; Projected 2008, 2025)
• Figure 4-4: China Fertility Rates and Births (Estimated 2005, 2007; Projected 2008, 2025)
• Table 4-8: China Life Expectancy at Birth, 1980, 1990, 2000, 2004, 2005, 2006, 2007; Projections, 2008 through 2012, and 2025
• Figure 4-5: China Life Expectancy at Birth by Sex, 1980, 1990, 2000, Projections 2025
• Table 4-9: China Mortality Rates and Numbers (Estimated 2005, 2007; Projected 2008, 2025)
• Figure 4-6: China Mortality Rates and Numbers (Estimated 2005, 2007; Projected 2008, 2025)
• Table 4-10: China Leading Causes of Death, Estimated 2007
• Figure 4-7: China Leading Causes of Death, Estimated 2007
• Table 4-11: HIV Indicators, China
• Figure 4-8: HIV Indicators, China
• Table 4-12: Tuberculosis Surveillance and Epidemiology, China
• Figure 4-9: Tuberculosis Surveillance and Epidemiology, China
• Table 4-13: China Malaria Data, 1990-2003
• Figure 4-10: China Malaria Data, 1990-2003
• Table 4-14: Cancer Surveillance and Epidemiology, China
• Table 4-15: Estimated Cancer Incidence in China by Most Common Types of Cancer, Compared to World, 2007
• Figure 4-11: Estimated Cancer Incidence in China by Most Common Types of Cancer, Compared to World, 2007
• Table 4-16: China Pharmaceutical Market Analysis, 2005-2007
• Table 4-17: Forecasted China Pharmaceutical Market Analysis: 2008-2012
• Figure 4-12: China Pharmaceutical Market Analysis: 2005-2012
• Table 4-18: China Pharmaceutical Market Analysis and Forecast by Product Segment, 2007 and 2012
• Figure 4-13: China Pharmaceutical Market Analysis by Product Segment, 2007
• Figure 4-14: China Pharmaceutical Market Forecast by Product Segment, 2012
• Table 4-19: Estimated Sales of Pharmaceuticals in China by Local and Foreign Suppliers, 2007
• Figure 4-15: Estimated Sales of Pharmaceuticals in China by Local and Foreign Suppliers, 2007

• Table 5-1: Russia Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
• Figure 5-1: Russia Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
• Table 5-2: Russia' s Economic Profile
• Table 5-3: Gross National Income Per Capita and Growth Comparison for 2005 and 2006
• Table 5-4: Healthcare Professionals in Russia by Type, Estimated 2004 and 2007
• Figure 5-2: Healthcare Professionals in Russia by Type, Estimated 2004 and 2007
• Table 5-5: Russia - Midyear Population, by Age and Sex, 2007 and 2012
• Figure 5-3: Russia - Midyear Population, by Age 2007 and 2012
• Table 5-6: Russia Fertility Rates and Births (Estimated 2005, 2007; Projected 2008, 2025)
• Figure 5-4: Russia Fertility Rates and Births (Estimated 2005, 2007; Projected 2008- 2025)
• Table 5-7: Russia Life Expectancy at Birth, 2005, 2006, 2007; (Projections, 2008 through 2012, and 2025)
• Figure 5-5: Russia Life Expectancy at Birth by Sex, 2005; Projections 2010 and 2025
• Table 5-8: Russia Mortality Rates and Numbers (Estimated 2005, 2007; Projected 2008, 2025)
• Figure 5-6: Russia Mortality Rates and Numbers Estimated 2005, 2007; Projected 2008, 2025
• Table 5-9: Russia Leading Causes of Death, Estimated 2007
• Figure 5-7: Russia Leading Causes of Death, Estimated 2007
• Table 5-10: HIV Indicators, Russia
• Figure 5-8: HIV Indicators, Russia
• Table 5-11: Tuberculosis Surveillance and Epidemiology, Russia
• Figure 5-9: Tuberculosis Surveillance and Epidemiology, Russia
• Table 5-12: Cancer Surveillance and Epidemiology, Russia
• Table 5-13: Estimated Cancer Incidence in Russia by Most Common Types of Cancer, Compared to World, 2007
• Figure 5-10: Estimated Cancer Incidence in Russia by Most Common Types of Cancer, Compared to World, 2007
• Table 5-14: Russia Pharmaceutical Market Analysis, 2005-2007
• Table 5-15: Forecasted Russia Pharmaceutical Market Analysis: 2008-2012
• Figure 5-11: Russia Pharmaceutical Market Analysis: 2005-2012
• Table 5-16: Russia Pharmaceutical Market Analysis and Forecast by Product Segment, 2007 and 2012
• Figure 5-12: Russia Pharmaceutical Market Analysis by Product Segment, 2007
• Figure 5-13: Russia Pharmaceutical Market Forecast by Product Segment, 2012
• Table 5-17: Estimated Sales of Pharmaceuticals in Russia by Local and Foreign Suppliers, 2007
• Figure 5-14: Estimated Sales of Pharmaceuticals in Russia by Local and Foreign Suppliers, 2007

• Table 6-1: Brazil Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
• Figure 6-1: Brazil Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
• Table 6-2: Brazil' s Economic Profile
• Table 6-3: Gross National Income Per Capita and Growth Comparison for 2005 and 2006
• Table 6-4: Healthcare Professionals in Brazil by Type, Estimated 2004 and 2007
• Figure 6-2: Healthcare Professionals in Brazil by Type, Estimated 2004 and 2007
• Table 6-5: Brazil - Midyear Population, by Age and Sex, 2007 and 2012
• Figure 5-3: Brazil - Midyear Population, by Age and Sex, 2007 and 2012
• Table 6-6: Brazil Fertility Rates and Births
• Figure 6-4: Brazil Fertility Rates and Births
• Table 6-7: Brazil Life Expectancy at Birth, 2000, 2005, 2006, 2007; Projections, 2008 through 2012, and 2025
• Figure 6-5: Brazil Life Expectancy at Birth by Sex, 2000, 2005; Projections 2010, 2025
• Table 6-8: Brazil Mortality Rates and Numbers
• Figure 6-6: Brazil Mortality Rates and Numbers
• Table 6-9: Brazil Leading Causes of Death, Estimated 2007
• Figure 6-7: Brazil Leading Causes of Death, Estimated 2007
• Table 6-10: Tuberculosis Surveillance and Epidemiology, Brazil
• Figure 6-8: Tuberculosis Surveillance and Epidemiology, Brazil
• Table 6-11: HIV Indicators, Brazil
• Figure 6-9: HIV Indicators, Brazil
• Table 6-12: Brazil Malaria Data, 1990-2003
• Figure 6-10: Brazil Malaria Data, 1990-2003
• Table 6-13: Cancer Surveillance and Epidemiology, Brazil
• Table 6-14: Estimated Cancer Incidence in Brazil by Most Common Types of Cancer, Compared to World
• Figure 6-11: Estimated Cancer Incidence in Brazil by Most Common Types of Cancer, Compared to World, 2007
• Table 6-15: Brazil Pharmaceutical Market Analysis, 2005-2007
• Table 6-16: Forecasted Brazil Pharmaceutical Market Analysis: 2008-2012
• Figure 6-12: Brazil Pharmaceutical Market Analysis: 2005-2012
• Table 6-17: Brazil Pharmaceutical Market Analysis and Forecast by Product Segment, 2007 and 2012
• Figure 6-13: Brazil Pharmaceutical Market Analysis by Product Segment, 2007
• Figure 6-14: Brazil Pharmaceutical Market Forecast by Product Segment, 2012
• Table 6-18: Estimated Sales of Pharmaceuticals in Brazil by Local and Foreign Suppliers, 2007
• Figure 6-15: Estimated Sales of Pharmaceuticals in Brazil by Local and Foreign Suppliers, 2007

• Table 7-1: BRIC Market Analysis, 2005-2007
• Table 7-2: Forecasted BRIC Market Analysis: 2008-2012
• Figure 7-1: BRIC Market Analysis: 2005-2012
• Table 7-3: World Pharmaceutical Markets by Country/Region, 2007
• Figure 7-2: World Pharmaceutical Markets by Country/Region, 2007